We are monitoring the impact of COVID-19 on APAC DNA Sequencing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 11472
Share on
Share on

APAC DNA Sequencing Market Research Report – Segmented By Product & Services, Technology, Workflow, Application, End User, and Country (APAC - India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore and Rest of APAC) - Industry Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 11472
Pages: 100

APAC DNA Sequencing Market Size (2021 to 2026)

The size of the DNA sequencing market in the Asia-Pacific is estimated to be growing at a healthy CAGR of 18.45% between 2021 to 2026.

Factors such as increasing demand for animal and plant breeders expanded research and development activities, and the acceptance of advanced technology is pushing the Asia-Pacific DNA Sequencing market. Furthermore, the proliferation of cancer and the expansion of biopsy applications are anticipated to accelerate the market. Newmarket players have been attracted to the APAC region's DNA sequencing market, fueling the region's market growth. The growing cancer occurrence has a significant impact on the DNA sequencing market. Besides that, the increasing use of genome mapping systems in Asian countries fuels market growth.

Furthermore, favorable government incentives, investment, and funding for infrastructure improvements facilities would boost the market growth. DNA sequencing is a highly accurate and high-throughput technology, and it has created a new form of genomic research. DNA sequencing is used in various applications, including biomarkers, personalized medicine, oncology research, and forensics. Advances in molecular biology have improved the sequencing protocols as the. The market has grown significantly in recent years due to several industry leaders introducing innovative NGS technologies. The cloud-based hub streamlines genomics data storage, maintenance, and analysis. In the same way, initiatives and innovations in emerging markets are expected to stimulate market growth. Cost-effectiveness and current conversion parameters to generate efficient outcomes in genome medicines are likely to impact market growth.

The significant concerns such as accuracy and standardization and ethical and legal limitations associated with DNA sequencing are expected to diminish the market growth. 

Impact of COVID-19 on the APAC DNA sequencing market:

The spread of SARS-COV-2 showed a positive impact on the APAC regional DNA Sequencing market. COVID-19 began in Wuhan, China, in 2019. Many pharmaceutical and biopharmaceutical firms and key market players, and DNA Sequencing start-ups are emerging to contribute to regional research efforts in developing COVID-19 kits, vaccines, and therapies. Emerging economies like China and India have expanded their R&D efforts to produce vaccines and drugs to fight the novel coronavirus. Researchers from Fuyang City (China) were the first to sequence COVID-19 samples using the Oxford Nanopore Technologies (UK) MinION Mk1C. Nanopore products for rapid molecular diagnostics are being developed in China by increasing public health and CDC laboratories. The APAC regional market for DNA sequencing is expected to grow faster in the coming years.

This research report on the APAC DNA sequencing market has been segmented and sub-segmented into the following categories.

By Product & Services:

  • Consumables
  • Instruments
  • Services

By Technology:

  • Sanger Sequencing
  • Next-Generation Sequencing
  • Whole Genome Sequencing (WGS)
  • Whole Exome Sequencing (WES)
  • Targeted Sequencing & Resequencing
  • Third Generation DNA Sequencing  
  • Single-Molecule Real-Time Sequencing (SMRT)
  • Nanopore Sequencing

By Workflow:

  • Pre-sequencing
  • Sequencing
  • Data Analysis

By Application:

  • Oncology
  • Reproductive Health
  • Clinical Investigation
  • Agri genomics & Forensics
  • HLA Typing/Immune System Monitoring
  • Metagenomics, Epidemiology & Drug Development
  • Consumer Genomics
  • Others

By End-use:

  • Academic Research
  • Clinical Research
  • Hospitals & Clinics
  • Pharmaceutical & Biotechnology Companies
  • Other Users

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the growing applications of DNA sequencing are strongly favoring the APAC market to lead the global DNA sequencing market during the forecast period. The APAC DNA sequencing market is expected to be driven by an increment in the amount of genome mapping programs in this region and increased research and development activities. China, India, and Japan are the region's significant contributors.

China led the APAC region's largest DNA sequencing market in the recent past. The presence of specialized healthcare services and continued technological advances in DNA sequencing by key market participants have resulted in a substantial market share. During the COVID-19 pandemic, Fuyang City (China) researchers were the first to sequence COVID-19 samples using the Oxford Nanopore Technologies (UK) MinION Mk1C, resulting in a positive impact on regional market growth.

The Indian DNA sequencing market is expected to expand at a rapid pace over the forecast period. Favorable government incentives and programs are anticipated to accelerate market growth. However, the government's increased investments in healthcare infrastructure stimulate the Indian DNA sequencing market. The availability of advanced clinical laboratories and successful market players is anticipated to push the market growth in the coming years. 

Japan is expected to contribute a moderate market share to the APAC regional market. The growing access to affordable genotyping assistance and the prevalence of generative alignment and personalized medicine are driving the market growth in this region.

KEY MARKET PLAYERS:

Some of the promising companies dominating the APAC DNA sequencing market analyzed in this report are Agilent Technologies, Inc., Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), F. Hoffmann-La Roche Ltd, Illumina, Inc., LI-COR Biosciences, Inc., Pacific Biosciences of California, Inc., SIEMENS AG, PerkinElmer Inc., and Thermo Fisher Scientific, Inc.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year, and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
  6. MARKET SEGMENTATION
    1. Products and Services
      1. Consumables
      2. Instruments
      3. Services
      4. Y-o-Y Growth Analysis, By Products and Services
      5. Market Attractiveness Analysis, By Products and Services
      6. Market Share Analysis, By Products and Services
    2. By Technology
      1. Sanger Sequencing
      2. Next-Generation Sequencing
      3. Whole Genome Sequencing (WGS)
      4. Whole Exome Sequencing (WES)
      5. Targeted Sequencing & Resequencing
      6. Third Generation DNA Sequencing  
      7. Single-Molecule Real-Time Sequencing (SMRT)
      8. Nanopore Sequencing
      9. Y-o-Y Growth Analysis, By Technology
      10. Market Attractiveness Analysis, By Technology
      11. Market Share Analysis, By Technology
    3. By Workflow
      1. Pre-sequencing
      2. Sequencing
      3. Data Analysis
      4. Y-o-Y Growth Analysis, By Workflow
      5. Market Attractiveness Analysis, By Workflow
      6. Market Share Analysis, By Workflow
    4. By Application
      1. Oncology
      2. Reproductive Health
      3. Clinical Investigation
      4. Agri genomics & Forensics
      5. HLA Typing/Immune System Monitoring
      6. Metagenomics, Epidemiology & Drug Development
      7. Consumer Genomics
      8. Others
      9. Y-o-Y Growth Analysis, By Application
      10. Market Attractiveness Analysis, By Application
      11. Market Share Analysis, By Application
    5. By End-User
      1. Academic Research
      2. Clinical Research
      3. Hospitals & Clinics
      4. Pharmaceutical & Biotechnology Companies
      5. Other Users
      6. Y-o-Y Growth Analysis, By End User
      7. Market Attractiveness Analysis, By End User
      8. Market Share Analysis, By End User
  7. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia and NZ
      7. Rest of APAC
  8. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. The threat of New Entrants
      4. The threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  9. MARKET LEADERS' ANALYSIS
    1. Abbott Laboratories
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Agilent Technologies, Inc.
    3. Danaher Corporation (Beckman Coulter, Inc.)
    4. F. Hoffmann-La Roche Ltd
    5. Illumina, Inc.
    6. LI-COR Biosciences, Inc.
    7.  Pacific Biosciences of California, Inc.
    8.  SIEMENS AG
    9. PerkinElmer Inc.,
    10. Thermo Fisher Scientific, Inc.
  10. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations, and Joint Ventures
    4. New Product Launches
  11. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  12. APPENDIX
  13. List of Tables
  14. List of Figures
  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and identify the regions that are still untapped.
  • The segment-level analysis in terms of products and services, workflow, application, and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market, including broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine an Industry's overall profitability, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players and their proDNA Sequencing Marketduct portfolio, current strategic interests, key financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field, new product launches, comparative financial studies, and recent developments in the market by the major companies.
  • An executive summary abridges the entire report so that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview and investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Asia Pacific DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  2. Asia Pacific Consumables Market, By Region, From 2021 to 2026 (USD Billion)
  3. Asia Pacific Instruments Market, By Region, From 2021 to 2026 (USD Billion)
  4. Asia Pacific Services Market, By Region, From 2021 to 2026 (USD Billion)
  5. Asia Pacific DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  6. Asia Pacific Sanger Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  7. Asia Pacific Next-Generation Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  8. Asia Pacific Whole Genome Sequencing (WGS) Market, By Region, From 2021 to 2026 (USD Billion)
  9. Asia Pacific Whole Exome Sequencing (WES) Market, By Region, From 2021 to 2026 (USD Billion)
  10. Asia Pacific Targeted Sequencing & Resequencing Market, By Region, From 2021 to 2026 (USD Billion)
  11. Asia Pacific Third Generation DNA Sequencing   Market, By Region, From 2021 to 2026 (USD Billion)
  12. Asia Pacific Single-Molecule Real-Time Sequencing (SMRT) Market, By Region, From 2021 to 2026 (USD Billion)
  13. Asia Pacific Nanopore Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  14. Asia Pacific DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  15. Asia Pacific Pre-sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  16. Asia Pacific Sequencing Market, By Region, From 2021 to 2026 (USD Billion)
  17. Asia Pacific Data Analysis Market, By Region, From 2021 to 2026 (USD Billion)
  18. Asia Pacific DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  19. Asia Pacific Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  20. Asia Pacific Reproductive Health Market, By Region, From 2021 to 2026 (USD Billion)
  21. Asia Pacific Clinical Investigation Market, By Region, From 2021 to 2026 (USD Billion)
  22. Asia Pacific Agrigenomics & Forensics Market, By Region, From 2021 to 2026 (USD Billion)
  23. Asia Pacific HLA Typing/Immune System Monitoring Market, By Region, From 2021 to 2026 (USD Billion)
  24. Asia Pacific Metagenomics, Epidemiology & Drug Development Market, By Region, From 2021 to 2026 (USD Billion)
  25. Asia Pacific Consumer Genomics Market, By Region, From 2021 to 2026 (USD Billion)
  26. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  27. Asia Pacific DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  28. Asia Pacific Academic Research Market, By Region, From 2021 to 2026 (USD Billion)
  29. Asia Pacific Clinical Research Market, By Region, From 2021 to 2026 (USD Billion)
  30. Asia Pacific Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  31. Asia Pacific Pharmaceutical & Biotechnology Companies Market, By Region, From 2021 to 2026 (USD Billion)
  32. Asia Pacific Other Users Market, By Region, From 2021 to 2026 (USD Billion)
  33. Japan DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  34. Japan DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  35. Japan DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  36. Japan DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  37. Japan DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  38. China DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  39. China DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  40. China DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  41. China DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  42. China DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  43. India DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  44. India DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  45. India DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  46. India DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  47. India DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  48. Australia DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  49. Australia DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  50. Australia DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  51. Australia DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  52. Australia DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)
  53. South Korea DNA Sequencing Market, By Product & Services, From 2021 to 2026 (USD Billion)
  54. South Korea DNA Sequencing Market, By Technology, From 2021 to 2026 (USD Billion)
  55. South Korea DNA Sequencing Market, By Workflow, From 2021 to 2026 (USD Billion)
  56. South Korea DNA Sequencing Market, By Application, From 2021 to 2026 (USD Billion)
  57. South Korea DNA Sequencing Market, By End-use, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample